GO terms (false discovery rate <0.05) enriched in both DB and Karpas 422 (that is, specific for GCB-DLBCL) or both OCI-Ly3 and HBL-1 (that is, specific for ABC-DLBCL) were identified (Supplementary Table S1). This evidence concerns the gene CD8B and diffuse large B-cell lymphoma.